CD4 and melanoma: In the present study, we demonstrate that vaccination with ITI-3000 induces potent, antigen-specific CD4 T cell responses and a strong humoral response that were sufficient to delay tumor growth of an orthotopic, syngeneic B16F10 melanoma line expressing LTS220A.